Aerovate Therapeutics Correlations

AVTE Stock

USD 2.52 0.02 0.80%

The current 90-days correlation between Aerovate Therapeutics and Pliant Therapeutics is 0.07 (i.e., Significant diversification). The correlation of Aerovate Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Aerovate Therapeutics Correlation With Market

Good diversification

The correlation between Aerovate Therapeutics and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aerovate Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.

Moving together with Aerovate Stock

0.65	ELVN	Enliven Therapeutics	Pair Corr
0.64	SCLX	Scilex Holding	Pair Corr
0.68	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.66	CRNX	Crinetics Pharmaceuticals	Pair Corr

Moving against Aerovate Stock

0.71	LUCD	Lucid Diagnostics	Pair Corr
0.7	WM	Waste Management	Pair Corr
0.56	GE	GE Aerospace	Pair Corr
0.41	PG	Procter Gamble	Pair Corr
0.33	PLX	Protalix Biotherapeutics	Pair Corr
0.69	DD	Dupont De Nemours	Pair Corr
0.67	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.66	CSCO	Cisco Systems	Pair Corr
0.66	T	ATT Inc Sell-off Trend	Pair Corr
0.61	INTC	Intel Sell-off Trend	Pair Corr
0.58	CVX	Chevron Corp	Pair Corr
0.57	IBM	International Business	Pair Corr
0.51	MMM	3M Company	Pair Corr
0.48	XOM	Exxon Mobil Corp Earnings Call Next Week	Pair Corr

Related Correlations Analysis

	DAWN	REPL	MIRM	RCKT	RNA	QURE	PTGX	PLRX	IMCR	RVMD
DAWN		0.43	0.19	0.71	0.12	0.52	-0.71	0.63	0.38	0.7	DAWN
REPL	0.43		0.62	0.27	0.42	0.03	-0.38	0.03	0.41	0.39	REPL
MIRM	0.19	0.62		-0.16	0.51	-0.33	-0.19	-0.3	0.23	-0.04	MIRM
RCKT	0.71	0.27	-0.16		-0.02	0.76	-0.54	0.85	0.3	0.9	RCKT
RNA	0.12	0.42	0.51	-0.02		0.21	0.2	-0.15	0.14	0.23	RNA
QURE	0.52	0.03	-0.33	0.76	0.21		-0.07	0.79	0.32	0.72	QURE
PTGX	-0.71	-0.38	-0.19	-0.54	0.2	-0.07		-0.45	-0.33	-0.45	PTGX
PLRX	0.63	0.03	-0.3	0.85	-0.15	0.79	-0.45		0.39	0.73	PLRX
IMCR	0.38	0.41	0.23	0.3	0.14	0.32	-0.33	0.39		0.26	IMCR
RVMD	0.7	0.39	-0.04	0.9	0.23	0.72	-0.45	0.73	0.26		RVMD
	DAWN	REPL	MIRM	RCKT	RNA	QURE	PTGX	PLRX	IMCR	RVMD

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RVMD	+ 0.9	RCKT
PLRX	+ 0.85	RCKT
PLRX	+ 0.79	QURE
QURE	+ 0.76	RCKT
RVMD	+ 0.73	PLRX
RVMD	+ 0.72	QURE

High negative correlations

PTGX	- 0.71	DAWN
PTGX	- 0.54	RCKT
RVMD	- 0.45	PTGX
PLRX	- 0.45	PTGX
PTGX	- 0.38	REPL
IMCR	- 0.33	PTGX

Risk-Adjusted Indicators

There is a big difference between Aerovate Stock performing well and Aerovate Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aerovate Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DAWN	2.88	(0.52)	0.00	(0.61)	0.00	0.00	6.36	(6.67)	22.86
REPL	2.86	(0.07)	0.00	(0.08)	0.00	0.00	5.86	(5.88)	23.59
MIRM	1.89	0.19	0.11	(0.69)	1.82	(2.41)	5.32	(2.73)	13.96
RCKT	2.78	(0.45)	0.00	0.70	0.00	0.00	4.92	(6.06)	12.71
RNA	2.96	0.16	0.06	2.02	2.97	(3.78)	7.22	(4.63)	20.15
QURE	3.81	(0.16)	0.00	0.19	0.00	0.00	6.84	(9.75)	26.06
PTGX	2.79	0.45	0.20	(0.34)	2.47	(3.47)	3.48	(3.74)	50.66
PLRX	6.66	(2.24)	0.00	1.35	0.00	0.00	10.39	(14.98)	80.84
IMCR	2.14	0.09	0.04	0.29	2.49	(2.26)	5.34	(4.18)	10.97
RVMD	1.73	(0.21)	0.00	0.21	0.00	0.00	4.37	(5.89)	11.35

Aerovate Therapeutics Corporate Management

Timothy Pigot	VP Commercial	Profile
Sanjeev Khindri	Executive Development	Profile
Benjamin Dake	President, Founder	Profile
Timothy MBA	CEO Director	Profile
Marinus Verwijs	Chief Officer	Profile
Stephen Yu	Senior Quality	Profile
BSc MD	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC